Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Combining statins with interferon β in multiple sclerosis: think twice, it might not be all right.

Zamvil SS, Steinman L.

Lancet Neurol. 2011 Aug;10(8):672-3. doi: 10.1016/S1474-4422(11)70153-3. No abstract available.

2.

[PRISMS study. Interferon beta-1a therapy in relapsing-remitting multiple sclerosis].

Limmroth V.

Internist (Berl). 2001 Feb;42(2):305-7. Review. German. No abstract available.

PMID:
11244885
3.

Efficacy of statins in combination with interferon therapy in multiple sclerosis: a meta-analysis.

Bhardwaj S, Coleman CI, Sobieraj DM.

Am J Health Syst Pharm. 2012 Sep 1;69(17):1494-9. doi: 10.2146/ajhp110675. Review.

PMID:
22899744
4.

Emerging methods for evaluating the effectiveness of intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis.

Foley JF, Barnes CJ, Nair KV.

J Manag Care Pharm. 2013 Jan-Feb;19(1 Suppl A):S16-23. Review.

5.

Peginterferon beta-1a (Plegridy) for multiple sclerosis.

[No authors listed]

Med Lett Drugs Ther. 2015 May 11;57(1468):67-9. Review.

PMID:
25941954
6.

Subcutaneous recombinant interferon-β-1a (Rebif®): a review of its use in the treatment of relapsing multiple sclerosis.

Sanford M, Lyseng-Williamson KA.

Drugs. 2011 Oct 1;71(14):1865-91. doi: 10.2165/11207540-000000000-00000. Review.

PMID:
21942977
7.

[Subcutaneous interferon-beta-1a in the treatment of multiple sclerosis].

Fertl E, Krichmayr M.

Wien Med Wochenschr. 2008;158(3-4):98-109. doi: 10.1007/s10354-008-0510-6. Review. German.

PMID:
18330526
8.

Multiple sclerosis.

Boggild M, Ford H.

Clin Evid. 2002 Jun;(7):1195-207. Review. No abstract available. Update in: Clin Evid. 2003 Jun;(9):1459-73.

PMID:
12230737
9.

Recombinant human interferon beta in relapsing-remitting multiple sclerosis: a review of the major clinical trials.

Chofflon M.

Eur J Neurol. 2000 Jul;7(4):369-80. Review. Erratum in: Eur J Neurol 2000 Sep;7(5):593.

PMID:
10971595
11.

Subcutaneous IFN-β1a to treat relapsing-remitting multiple sclerosis.

Thouvenot E, Carlander B, Camu W.

Expert Rev Neurother. 2012 Nov;12(11):1283-91. doi: 10.1586/ern.12.122. Epub 2012 Nov 11. Review.

PMID:
23140228
12.

Fingolimod for relapsing-remitting multiple sclerosis.

La Mantia L, Tramacere I, Firwana B, Pacchetti I, Palumbo R, Filippini G.

Cochrane Database Syst Rev. 2016 Apr 19;4:CD009371. doi: 10.1002/14651858.CD009371.pub2. Review.

PMID:
27091121
13.
14.
15.

[Clinical efficacy and safety of long-term immunomodulating therapy with interferon beta].

Demina TL, Khachanova NV, Davydovskaia MV, Popova NF, Gusev EI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):24-6. Review. Russian. No abstract available.

PMID:
18567192
16.

Long-term benefits of early and high doses of interferon beta-1a treatment in relapsing-remitting multiple sclerosis.

Chofflon M, Ben-Amor AF.

Clin Neurol Neurosurg. 2002 Jul;104(3):244-8. Review. No abstract available.

PMID:
12127662

Supplemental Content

Support Center